generics

Martin Shkreli continued to orchestrate anti-competitive schemes for Daraprim behind bars — FTC
Endpoints
Fri, 08/14/20 - 09:53 am
Martin Shkreli
Daraprim
FTC
generics
Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market
Drug Patent Watch
Wed, 08/12/20 - 10:43 am
generics
FDA
drug approvals
Apixaban
Bristol Myers, Pfizer fend off a key challenge to their top-selling heart drug
BioPharma Dive
Thu, 08/6/20 - 10:27 am
Bristol-Myers Squibb
Pfizer
patents
Eliquis
generics
Delaware
Biogen's last-ditch pitch for an injunction to protect Tecfidera is denied, paving way for Mylan generic
Endpoints
Fri, 07/31/20 - 10:46 am
Biogen
Tecfidera
Mylan
generics
Teva, Takeda offload generics, manufacturing plant to Nichi-Iko in Japanese venture reshuffle
Fierce Pharma
Thu, 07/30/20 - 11:14 am
Teva Pharmaceutical
Takeda
Japan
generics
drug manufacturing
Camera maker Kodak dives into drug manufacturing with $765M federal loan
Fierce Pharma
Thu, 07/30/20 - 11:09 am
Kodak
APIs
Defense Production Act
drug manufacturing
pandemic
generics
COVID-19
FDA kicks off GDUFA III reauthorization process
RAPS.org
Wed, 07/22/20 - 12:00 am
FDA
generics
regulatory
GDUFA
Teva to serve as defendant in bellwether trial alleging generic drug price-fixing
Beckers Hospital Review
Thu, 07/16/20 - 11:05 am
Teva Pharmaceutical
generics
drug pricing
price fixing
Novartis to provide 'no profit' COVID-19 drugs to low income countries
Reuters
Thu, 07/16/20 - 11:00 am
Novartis
Sandoz
non-profits
developing countries
generics
Philadelphia generic drugmaker slashes workforce by 8.5% after competitor emerges
Beckers Hospital Review
Mon, 07/13/20 - 11:39 pm
Lannett
layoffs
Amneal
Fluphenazine
generics
antipsychotics
Mylan and Pfizer roll out tricolor branding for their giant generics combo, Viatris
Fierce Pharma
Thu, 07/9/20 - 12:39 pm
Mylan
Pfizer
Upjohn
M&A
generics
Viatris
branding
US warns that 2nd COVID-19 wave could worsen generic drug shortages
Beckers Hospital Review
Tue, 06/30/20 - 10:46 am
generics
drug shortages
pandemic
COVID-19
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Fierce Pharma
Wed, 06/24/20 - 11:18 pm
Mylan
patents
generics
Novo Nordisk
Victoza
diabetes
Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch
Fierce Pharma
Mon, 06/22/20 - 08:36 pm
Biogen
Tecfidera
Mylan
patents
generics
MS
multiple sclerosis
A new hope for Amarin? Vascepa generic settlement leaves analysts split on patent appeal success
Fierce Pharma
Wed, 06/17/20 - 10:20 pm
Amarin
Vascepa
generics
Apotex
U.S. states accuse 26 drugmakers of generic drug price fixing in sweeping lawsuit
Reuters
Wed, 06/10/20 - 11:53 pm
price fixing
generics
drug pricing
FDA issues 69 new and revised draft product-specific guidances
RAPS.org
Wed, 06/3/20 - 11:31 pm
FDA
generics
FDA approves the first generic for Amarin's Vascepa — but is a launch imminent?
Endpoints
Fri, 05/22/20 - 11:03 am
FDA
Amarin
Vascepa
Hikma
generics
Bangladesh pharma claims to be first to launch generic remdesivir
BioPharma Dive
Thu, 05/21/20 - 11:08 pm
Bangladesh
Beximco
generics
remdesivir
Gilead Sciences
COVID-19
Generic drugmaker Akorn files for bankruptcy
Beckers Hospital Review
Thu, 05/21/20 - 10:22 am
Akorn
generics
bankruptcy

Pages